Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Rachel B Abraham
Observed name:
Rachel B. Abraham
Institution:
University of Arizona
Observed institution:
University of Arizona
ORCID:
0000-0003-1540-3024
Observed ORCID:
0000-0003-1540-3024
OpenAlex ID:
A5011843162
Comparing jurisdiction-specific pharmaco-economic evaluations using medical purchasing power parities
2021
·
Briana M. Choi
, Rachel B. Abraham
, et al.
·
Journal of Medical Economics
·
10
PDF
Economic evaluations of adjunctive osimertinib treatment in surgically resected epidermal growth factor receptor positive (EGFR+) non-small cell lung cancer (NSCLC): Analysis for stage 1B disease.
2022
·
Briana M Choi
, Rachel B Abraham
, et al.
·
Journal of Clinical Oncology
Economic evaluations of adjunctive osimertinib treatment in surgically resected epidermal growth factor receptor positive (EGFR+) non-small cell lung cancer (NSCLC): Analysis for stage 3A disease.
2022
·
Mavis Obeng-Kusi
, Briana M Choi
, et al.
·
Journal of Clinical Oncology
Economic evaluations of adjunctive osimertinib treatment in surgically resected epidermal growth factor receptor-positive (EGFR+) non-small cell lung cancer (NSCLC): Analysis for stage 2 disease.
2022
·
Briana M Choi
, Osama Aqel
, et al.
·
Journal of Clinical Oncology
Show more works
View as search
Works count:
4
Citation count:
10
H-index:
1
I10-index:
1
Year
Topic
Type